Ronald C. Renaud Jr.

Filings by Ronald C. Renaud Jr. span 6 companies, the busiest being Translate Bio, Inc., Idenix Pharmaceuticals Inc and Cerevel Therapeutics Holdings, Inc. In total, 24 filings cover trades dated from 14 February 2007 to 1 August 2024.

In open-market terms, that means 3 purchases worth €1.9M on one side and 3 sales worth €30.7M on the other. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants and 9 option exercises.

The newest entry dates from 5 August 2024: a transaction, in Cerevel Therapeutics Holdings, Inc. The clock since the last published purchase (7 August 2023) now reads 1,174 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.